Adam E. Frampton
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 54
- Pancreatic and Hepatic Oncology Research 42
- Cancer Cells and Metastasis 8
-
- MicroRNA in disease regulation 29
- Cancer-related molecular mechanisms research 10
- Cancer Genomics and Diagnostics 9
- Co-authors
- Jonathan Krell (46 shared papers)Justin Stebbing (41 shared papers)Long R. Jiao (33 shared papers)Leandro Castellano (33 shared papers)Elisa Giovannetti (36 shared papers)Tamara Gall (15 shared papers)Nagy Habib (18 shared papers)Loredana Pellegrino (10 shared papers)
- Journals
- Cancers (12 papers)Journal of Clinical Pathology (6 papers)Oncotarget (4 papers)Pancreatology (4 papers)PLoS ONE (3 papers)
- Partner nations
- United KingdomItalyNetherlands
In The Last Decade
Adam E. Frampton
132 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 1.2k
- Oncology 955
- Hepatology 197
- Molecular Biology 1.4k
- Immunology 195
Countries citing papers authored by Adam E. Frampton
This map shows the geographic impact of Adam E. Frampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam E. Frampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam E. Frampton more than expected).
Fields of papers citing papers by Adam E. Frampton
This network shows the impact of papers produced by Adam E. Frampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam E. Frampton. The network helps show where Adam E. Frampton may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam E. Frampton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 122 | |
| 2 | 2012 | 113 | |
| 3 | 2018 | 102 | |
| 4 | 2015 | 101 | |
| 5 | 2013 | 96 | |
| 6 | 2016 | 94 | |
| 7 | 2017 | 89 | |
| 8 | 2015 | 84 | |
| 9 | 2013 | 79 | |
| 10 | 2012 | 74 | |
| 11 | 2014 | 71 | |
| 12 | 2013 | 67 | |
| 13 | 2014 | 66 | |
| 14 | 2018 | 61 | |
| 15 | 2014 | 59 | |
| 16 | 2016 | 56 | |
| 17 | 2014 | 53 | |
| 18 | 2012 | 53 | |
| 19 | 2018 | 52 | |
| 20 | 2015 | 51 |
About Adam E. Frampton
Adam E. Frampton is a scholar working on Oncology, Cancer Research, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 135 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (42 papers), MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Cells and Metastasis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Extracellular vesicles in disease (8 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (955 citations), Hepatology (197 citations), Molecular Biology (1.4k citations) and Immunology (195 citations). Adam E. Frampton has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Jonathan Krell, Justin Stebbing, Long R. Jiao, Leandro Castellano, Elisa Giovannetti, Tamara Gall, Nagy Habib, Loredana Pellegrino, Jimmy Jacob and Mireia Mato Prado. Their work appears in journals such as Cancers, Journal of Clinical Pathology, Oncotarget, Pancreatology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.